S. J. O. Veldhuyzen van Zanten

Author

Also Known As

S J O VELDHUYZEN VAN ZANTEN, S J O Veldhuyzen van Zanten, S J Veldhuyzen van Zanten, S. J. O. VELDHUYZEN VAN ZANTEN, S. J. O. Veldhuyzen Van Zanten, S. J. O. Veldhuyzen van Zanten, S. J. O.VELDHUYZEN VAN ZANTEN, S.J.O Veldhuyzen van Zanten, S.J.O. Veldhuyzen Van Zanten, S.J.O. Veldhuyzen van Zanten

Publications

3.6K

Citations

H-Index

Concepts

All Affiliations

Dalhousie University McMaster University Queen Elizabeth II Health Sciences Centre AstraZeneca (Canada)University of Alberta

About

S. J. O. Veldhuyzen van Zanten is an author at Dalhousie University specializing in medicine, gastroenterology, and outcomes research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	783
2	Public Health	2	2	51
3	Health Sciences	1	1	22
4	Social Sciences	1	1	63
5	Biochemistry	1	1	19

S. J. O. Veldhuyzen van Zanten

Publications

Citations

H-Index

Page 1

	Year	Citations
Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn's Disease and Ulcerative Colitis Uri Gophna, Katrin Sommerfeld, Sharon Gophna, Journal of Clinical Microbiology	2006	548
Metronidazole resistance in <i>Helicobacter pylori</i> is due to null mutations in a gene (<i>rdxA</i>) that encodes an oxygen‐insensitive NADPH nitroreductase Avery Goodwin, Dangeruta Kersulyte, Gary Sisson, Molecular Microbiology	1998	352
Design of Treatment Trials for Functional Gastrointestinal Disorders E. Jan Irvine, William E. Whitehead, William D. Chey, Gastroenterology Functional Gastrointestinal DisorderGastroenterologyTreatment TrialsSurgeryMedicine	2006	282
The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment – Prompt Endoscopy (CADET–PE) study A. B. R. Thomson, Alan Barkun, David Armstrong, Alimentary Pharmacology & Therapeutics	2003	277
Increasing Prevalence of Helicobacter pylori Infection with Age: Continuous Risk of Infection in Adults Rather than Cohort Effect S. J. O. Veldhuyzen van Zanten, P. Timothy Pollak, Linda Best, The Journal of Infectious Diseases	1994	185
The DU‐MACH study: eradication of <i>Helicobacter pylori</i> and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy S. J. O. Veldhuyzen van Zanten, BRADETTE, Farley, Alimentary Pharmacology & Therapeutics	1999	127
The GU‐MACH study: the effect of 1‐week omeprazole triple therapy on <i>Helicobacter pylori</i> infection in patients with gastric ulcer Peter Malfertheiner, E. Bayerdörffer, U. Diete, Alimentary Pharmacology & Therapeutics	1999	124
Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and helicobacter pylori associated gastritis? S. J. O. Veldhuyzen van Zanten, Kristien M.A.J. Tytgat, P. Timothy Pollak, Journal of Clinical Epidemiology Outcome MeasureClinical FindingGastroenterologyDiagnosisOutcomes Research	1993	119
A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study S. J. O. Veldhuyzen van Zanten, Naoki Chiba, David Armstrong, The American Journal of Gastroenterology	2005	112
Validation of a 7‐point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials S. J. O. Veldhuyzen van Zanten, Naoki Chiba, David Armstrong, Alimentary Pharmacology & Therapeutics	2006	101

Page 1